Back to search
FDAFDA · Food and drugs·Recall number D-0002-2015

Marcaine (bupivacaine HCl) injection, USP, 0.5%, Preservative-Free, 30 mL (150 mg) Single-dose Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045 NDC 0409-1560-29

Published October 8, 2014 · Recall initiated: June 17, 2014

Summary

FDA records drug Class I recall D-0002-2015, published October 8, 2014 and initiated June 17, 2014. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 40,730 vials; Lot: Lot # 33-545-DD, Exp. 09/15. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: Confirmed customer complaint of discolored solution with visible metal particles embedded in the glass vial and visible in the solution.

What to do

Voluntary: Firm initiated · Press Release

Get an email if MARCAINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
MARCAINE
Manufacturer
Hospira Inc.
Distributor
Nationwide
Lot
Lot # 33-545-DD, Exp. 09/15
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Marcaine (bupivacaine HCl) injection, USP, 0.5%, Preservative-Free, 30 mL (150 mg) Single-dose Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045 NDC 0409-1560-29 recalled?

Yes. FDA published recall D-0002-2015 on October 8, 2014. Reported hazard: Presence of Particulate Matter: Confirmed customer complaint of discolored solution with visible metal particles embedded in the glass vial and visible in the solution.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: MARCAINE.